Track PRFX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$1.20M
Enterprise Value-$2.92M
Revenue (TTM)-
Net Income (TTM)-$17.67M
Free Cash Flow (TTM)-$8.93M
Financial Health
Cash$4.14M
Net Debt-$4.12M
Debt Ratio0
Debt to Equity0
Interest Coverage-1,836.25
Valuation (TTM)
Price to Sales-
Price to Earnings-0.07
EV to EBITDA0.16
Price to Book0.14
Price to Free Cash Flow-0.13
Margins (TTM)
Gross Profit Margin-
EBITDA Margin-
Operating Income Margin-
Net Income Margin-
Free Cash Flow Margin-
Returns (5Y Avg)
Return on Invested Capital-211.59%
Return on Assets-114.50%
Return on Equity-221.07%
Return on Total Capital-211.59%
Return on Capital Employed-200.43%
Dividend Summary
Dividend Yield-
Annual Dividend-
Payout Ratio-
Ex Dividend Date-
5-Year Dividend CAGR-
CAGR (5Y)
Revenue-
Diluted EPS-
Total Debt-
Capital Expenditures-
Free Cash Flow-
CAGR (3Y)
Revenue-
Diluted EPS-
Total Debt-
Capital Expenditures-
Free Cash Flow-
CAGR (1Y)
Revenue-
Diluted EPS-
Total Debt-
Capital Expenditures-
Free Cash Flow-
$1.18-$0.02|-1.69%
Last updated: Jul 22, 4:20 PM ET
52W High$17.95
52W Low$1.13
50D SMA$1.55
200D SMA$3.32
Volume282.33K
Painreform Ltd
65 Yigal Alon St., Tel Aviv-Yafo, Israel, 6744316
IPO
2020
Employees
6
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Insider Transactions
Quarterly buy vs. sell activity
No insider transactions data available for this period
Analyst Ratings
1 analysts covering
Hold100%recommend hold
Buy
0
Hold
1
Sell
0